Dr. Della'Zanna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2001 Medical Pkwy
Annapolis, MD 21401- Is this information wrong?
Education & Training
Philadelphia College of Osteopathic MedicineM.Sc., Vascular Surgery , 1996 - 1998- Albright CollegeB.S., Biology, 1998
Philadelphia College of Osteopathic MedicineResidency, Surgery, 1992 - 1997- Philadelphia College of Osteopathic MedicineClass of 1992
- Philadelphia College of Osteopathic MedicineM.C.Sc., Vascular Surgery
Certifications & Licensure
MD State License 2002 - 2024- MD State License 2004 - 2024
GA State License 1997 - 2005
PA State License 1993 - 2002- AOA Board of Surgery Surgery
- National Institutes of Health: Clinical Research CurriculumClinical Research Curriculum
Awards, Honors, & Recognition
- Certificate with Commendation, Clinical Research Curriculum National Institutes of Health, 2010
- FDA Group Recognition Award 2007
- CDER Team Excellence Award 2003, 2005
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsPhase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers.David S. Weinberg, Nathan R. Foster, Gary Della'Zanna, Ryan McMurray, Walter K. Kraft, Angela Pallotto, David Kastenberg, Leo Katz, Christopher H. Henry, Stephanie Mol...> ;Cancer Biology & Therapy. 2021 Oct 10
- 11 citationsRandomized phase II trial of polyphenon E versus placebo in patients at high risk of recurrent colonic neoplasiaFrank A. Sinicrope, Thomas R. Viggiano, Navtej S. Buttar, Louis M. Wong Kee Song, Kenneth W. Schroeder, Robert E. Kraichely, Mark V. Larson, Robert E. Sedlack, John B....> ;Cancer Prevention Research. 2021 Mar 1
- 32 citationsBioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.David S. Weinberg, Jieru E. Lin, Nathan R. Foster, Gary Della'Zanna, Asad Umar, Drew K. Seisler, Walter K. Kraft, David Kastenberg, Leo Katz, Paul J. Limburg, Scott A....> ;Cancer Prevention Research. 2017 Jun 1
- Join now to see all
Journal Articles
- A Combination of Esomeprazole and Aspirin Reduces Tissue Concentrations of Prostaglandin E(2) in Patients With Barrett's EsophagusFalk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, Romero Y, Marcon NE, Schnell T, Corley DA, Sharma P, Cruz-Correa MR, Hur C, Fleischer DE, Chak A, Devault KR, Wei..., Gastroenterology, 1/11/2012
- Phase IIA Trial Testing Erlotinib as an Intervention against Intraductal Pancreatic Mucinous NeoplasmsSteven Lipkin, John Lee, David Imagawa, Stephen M. Hewitt, Chris Tucker, Jason A. Zell, Vanessa Wong, Angela Garcia, Rachel Gonzalez, Gary Della Zanna, Ellen Richmond,..., Cancer Prev Res, 1/1/2011
Abstracts/Posters
- Aspirin Mediated Down-Regulation of Warburg Kinase AKT1 in Patients with Barrett's Esophagus: Implications in Neoplastic TransformationNavtej S. Buttar; Gary W. Falk; Cathrine J. DeMars; Sonia Chowdhury; Ahmed Elebiary; Anamay Sharma; Sidhartha Chaudhry; Nathan R. Foster; Katie L. Allen Ziegler; Yvonn..., Eleventh Annual AACR International Conference: Frontiers in Cancer Prevention Research, 1/16/2012
Professional Memberships
- Member
- Fellow
Hospital Affiliations
Anne Arundel Medical CenterAnnapolis, Maryland
External Links
- National Cancer Institute's Division of Cancer Preventionhttps://prevention.cancer.gov/
- National Cancer Institutehttp://www.cancer.gov/
- National Institutes of Healthhttp://www.nih.gov/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
